OWP
TECH icon

Obermeyer Wealth Partners’s Bio-Techne TECH Stock Holding History

Obermeyer Wealth Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-400,816
Closed -$43.4M – 236
2022
Q1 		$43.4M Buy
400,816
+3,860
+1% +$398K 2.6% 14
2021
Q4 		$51.3M Buy
396,956
+11,040
+3% +$1.35M 2.75% 17
2021
Q3 		$46.8M Buy
385,916
+3,448
+0.9% +$420K 2.59% 18
2021
Q2 		$43.1M Buy
382,468
+6,184
+2% +$651K 2.4% 22
2021
Q1 		$35.9M Buy
376,284
+215,852
+135% +$19.7M 2.21% 28
2020
Q4 		$12.7M Buy
160,432
+2,536
+2% +$184K 0.85% 36
2020
Q3 		$9.78M Buy
157,896
+9,752
+7% +$634K 0.73% 37
2020
Q2 		$9.78M Buy
+148,144
New +$8.87M 0.83% 32

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Obermeyer Wealth Partners's TECH Position: Q2 2022 in Review

Obermeyer Wealth Partners sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 400,816 shares — an estimated $43.4M sold.

Obermeyer Wealth Partners first reported a position in TECH in Q2 2020 and held it in 8 quarters. The position peaked at $51.3M in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

  • Obermeyer Wealth Partners reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
  • Obermeyer Wealth Partners sold 400,816 Bio-Techne shares in Q2 2022, an estimated $43.4M.
  • Obermeyer Wealth Partners first reported a position in Bio-Techne in Q2 2020 and held it in 8 quarters.
  • Obermeyer Wealth Partners's Bio-Techne position peaked at $51.3M in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Obermeyer Wealth Partners's 13F filing for Q2 2022, filed 15 Aug 2022.